Inhibition of cytochrome P450-mediated drug metabolism by a concomitantly administered second drug is one of the major causes of drug-drug interactions in humans. The present study reports on the first electrochemically-driven drug-drug interactions of human cytochrome P450 3A4 probed with erythromycin, ketoconazole, cimetidine, diclofenac and quinidine. Cytochrome P450 3A4 was immobilized on glassy carbon electrodes in the presence of a cationic polyelectrolyte, PDDA (poly(diallyldimethylammonium chloride)). Inhibition of the turnover of its substrate, erythromycin, was subsequently measured using chronoamperometry at increasing concentrations of different known inhibitors of this enzyme namely ketoconazole, cimetidine and diclofenac for which IC 50 values of 135nM, 80μM and 311μM were measured, respectively. Furthermore, heterotrophic cooperativity where the turnover of a first substrate is enhanced in the presence of a second one, was tested for the immobilized P450 3A4 enzyme. In this case, diclofenac 5-hydroxylation was stimulated by the presence of quinidine resulting in doubling of the potency of this inhibitor i.e. lowering the measured IC 50 of diclofenac from 311μM down to 157μM. The results obtained in this work confirm that bioelectrochemistry can be employed for in vitro studies of not only drug-drug interactions but also prediction of adverse drug reactions in this important P450 isozyme.

Drug-drug interactions and cooperative effects detected in electrochemically driven human cytochrome P450 3A4

SADEGHI, JILA;FERRERO, Silvia;DI NARDO, Giovanna;GILARDI, Gianfranco
2012

Abstract

Inhibition of cytochrome P450-mediated drug metabolism by a concomitantly administered second drug is one of the major causes of drug-drug interactions in humans. The present study reports on the first electrochemically-driven drug-drug interactions of human cytochrome P450 3A4 probed with erythromycin, ketoconazole, cimetidine, diclofenac and quinidine. Cytochrome P450 3A4 was immobilized on glassy carbon electrodes in the presence of a cationic polyelectrolyte, PDDA (poly(diallyldimethylammonium chloride)). Inhibition of the turnover of its substrate, erythromycin, was subsequently measured using chronoamperometry at increasing concentrations of different known inhibitors of this enzyme namely ketoconazole, cimetidine and diclofenac for which IC 50 values of 135nM, 80μM and 311μM were measured, respectively. Furthermore, heterotrophic cooperativity where the turnover of a first substrate is enhanced in the presence of a second one, was tested for the immobilized P450 3A4 enzyme. In this case, diclofenac 5-hydroxylation was stimulated by the presence of quinidine resulting in doubling of the potency of this inhibitor i.e. lowering the measured IC 50 of diclofenac from 311μM down to 157μM. The results obtained in this work confirm that bioelectrochemistry can be employed for in vitro studies of not only drug-drug interactions but also prediction of adverse drug reactions in this important P450 isozyme.
86
87
91
P450 3A4; drug metabolism; Electrochemistry; protein immobilisation; Enzyme Inhibitors
Sheila J. Sadeghi; Silvia Ferrero; Giovanna Di Nardo; Gianfranco Gilardi
File in questo prodotto:
File Dimensione Formato  
BIOJEC6602.pdf

non disponibili

Tipo di file: POSTPRINT (VERSIONE FINALE DELL’AUTORE)
Dimensione 547.2 kB
Formato Adobe PDF
547.2 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Sadeghi.pdf

accesso aperto

Tipo di file: POSTPRINT (VERSIONE FINALE DELL’AUTORE)
Dimensione 822.42 kB
Formato Adobe PDF
822.42 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/2318/99295
Citazioni
  • ???jsp.display-item.citation.pmc??? 3
  • Scopus 40
  • ???jsp.display-item.citation.isi??? 36
social impact